The Green Side of CBR
On February 12, 2015, Dr. Reinhild Kappelhoff, member of the CBR’s Overall Lab, won the 2015 Green Labs Fund for the project “Lancer Dishwasher 100-hole pipette rack”. It’s not the first time that CBR has won a Green Labs initiative…
“Protease Inhibitors in Drug Discovery” Conference Summary
Protease Inhibitors in Drug Discovery Conference was held on February 26-27, 2015 in San Diego, CA – hosted by GTCbio CBR members, Dr. Dieter Bromme and his postdoctoral fellow, Preety Panwar, attended the Protease Inhibitors in Drug Discovery Conference, where Preety presented her research on “Exosite inhibitors targeting cathepsin K in osteoporosis”. Her travel was […]
How does pathogen inactivation treatment compromise platelet quality? – p38MAPK
Dr. Zhongming Chen, a PDF at Dr. Dana Devine’s laboratory, discovered a novel role of p38MAPK in apoptosis in platelets treated with pathogen inactivation technology.
Karsan Lab Reveals a Novel Promoter of Tumorigenesis
The group demonstrated that loss of RBPJ mimics a Notch activation signal through the derepression of a cohort of genes that are also transcribed following Notch activation.
How flexible are your red blood cells? – Microfluidic deformability
A step forward in transfusion medicine may involve a new application of microfluidics technology to evaluate the quality of stored red blood cells (RBC).
Beyond clotting: Platelets have active immunoproteasomes!
This research adds to the growing body of evidence that platelets play a bigger role in the immune system than previously thought and suggests that these small cell fragments may have more surprises in store.
Prospects in Academia: We shall fight on the benches, We shall fight in the labs, We shall never surrender!
The combination of a Science PhD aligned with training or experience in business, writing, or any number of transferable skills makes a highly employable candidate who…
The Kizhakkedathu lab discovers a safe and biocompatible anticoagulant reversal agent
The researchers believe that the use of this new drug, possessing universal reversal capabilities, would be most effective in time sensitive high-risk surgeries.
The Overall lab characterizes a new digestion enzyme for proteomics
LysargiNase is an exciting new tool for the proteomic community with specific applications to studying modified protein forms.
Dr. Rafi Chapanian – Reflections of a Postdoc
Dr. Rafi Chapanian has recently joined Eupraxia Pharmaceuticals Inc. as a Staff Scientist. Eupraxia is a Vancouver based company dedicated to providing best-in-class treatment for some of the most prevalent diseases in the Western world, including arthritis and chronic pain. Coming from a Material Science and Engineering background, completing a postdoctorate at CBR had a […]